Hologic Inc
NASDAQ:HOLX

  • LAST PRICE
    79.9150
  • TODAY'S CHANGE (%)
    -3.8050 (-4.5449%)
  • Bid / Lots
    79.9000/ 2
  • Ask / Lots
    79.9400/ 2
  • Open / Previous Close
    79.9800 / 83.7200
  • Day Range
    77.5000
    81.1350
  • 52 Week Range
    66.9300
    84.6700
  • Volume
    1,501,313

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Advanced Medical Equipment Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
HOLX
Hologic Inc
19.4B
27.3x
---
ILMN
Illumina Inc
24.5B
-15.2x
---
WAT
Waters Corp
23.0B
36.9x
+7.16%
RVTY
Revvity Inc
15.4B
59.5x
-7.39%
BRKR
Bruker Corp
9.0B
24.7x
+20.48%
RMD
Resmed Inc
35.8B
32.4x
+19.48%
As of 2024-11-05

Company Information

Hologic, Inc. is a medical technology company focused on improving women's health and well-being through early detection and treatment. It is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. It also offers wireless breast surgery localization and lymphatic tracing solutions. GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.

Contact Information

Headquarters
250 Campus DriveMARLBOROUGH, MA, United States 1752
Phone
508-263-2900
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Stephen Macmillan
Chief Financial Officer
Karleen Oberton
Division President - Breast and Skeletal Health Solutions
Erik Anderson
President - Diagnostic Solutions
Jennifer Schneiders
Division President, GYN Surgical Solutions
Brandon Schnittker

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$19.4B
Revenue (TTM)
$4.0B
Shares Outstanding
232.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.98
EPS
$2.93
Book Value
$20.76
P/E Ratio
27.3x
Price/Sales (TTM)
4.9
Price/Cash Flow (TTM)
19.2x
Operating Margin
19.69%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.